Health-Care Overhaul Seen Boosting Drug Costs
Cancer patients could face high costs for medications under President Barack Obama's health care law, industry analysts and advocates warn.
medication
5 Ways to Cut the Cost of Allergy Relief
Looking for allergy relief? Prescriptions, rather than OTC remedies, are often more effective and cheaper in the long run.
Economic Woes Are Jeopardizing Americans' Health
In this economy, people aren't just cutting out luxuries, nearly half of Americans are skimping on necessities like medication and doctor visits -- drastic actions that could be dangerous to their health.
FDA Approves First New Lupus Drug in Half a Century
The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.
Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.
Big Pharma Looks Beyond Drugs to Smartphone Apps
Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren't drugs at all, from smartphone apps and educational websites to social media platforms and wireless devices, reports Ernst & Young.
Senators Propose a New Law to Address Drug Shortages
Health care providers have been reporting unprecedented shortages of prescription drugs, including vital medications such as chemotherapies and antibiotics. Under current law, the FDA has no power to act, so two senators have introduced a bill to help government get a handle on the problem.
Allergan Pays $600 Million to Settle Botox Charges
Pharmaceutical firm Allergan has settled criminal and civil charges that it promoted Botox for uses the FDA hadn't approved, agreeing to pay $600 million and enter into a "corporate integrity agreement." Allergan also dropped its related First Amendment lawsuit against the FDA.
